Vitae Pharmaceuticals (VTAE), Boehringer Ingelheim to End BACE Inhibitors Collaboration, Licensing Agreement
Tweet Send to a Friend
Vitae Pharmaceuticals (NASDAQ: VTAE) announced that Boehringer Ingelheim (BI) has notified Vitae that BI is ending the parties' collaboration and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE